Skip to main content
. 2023 Jul 11;49(9):1079–1089. doi: 10.1007/s00134-023-07138-0

Table 3.

Treatment during First 7 days by AKI diagnostic criteria in SA-AKI patients

Variable AKI diagnostic criteria p valueb
Urine output only, N = 5952a Creatinine only, N = 4642a Both, N = 2857a
Any
 Ventilation 4147 (70%) 2470 (53%) 1908 (67%)  < 0.001
 Invasive ventilation 3975 (67%) 2302 (50%) 1815 (64%)  < 0.001
 Non-invasive ventilation 357 (6%) 297 (6.4%) 159 (5.6%) 0.3
 Vasopressors 3762 (63%) 3476 (75%) 2419 (85%)  < 0.001
 Diuretics 2946 (49%) 2106 (45%) 1404 (49%)  < 0.001
 RRT 164 (2.8%) 827 (18%) 1432 (50%)  < 0.001
 Nephrotoxic antibiotics 1722 (29%) 1694 (36%) 1292 (45%)  < 0.001
Days of intervention
 Ventilation 2 (0, 5) 1 (0, 4) 2 (0, 6)  < 0.001
 Invasive ventilation 2 (0, 5) 0 (0, 3) 2 (0, 6)  < 0.001
 Non-invasive ventilation 0 (0, 0) 0 (0, 0) 0 (0, 0) 0.3
 Vasopressors 2 (0, 5) 1 (0, 4) 2 (0, 6)  < 0.001
 RRT 2 (0, 3) 2 (0, 3) 3 (1, 4)  < 0.001
 Diuretic 0 (0, 2) 0 (0, 2) 0 (0, 2)  < 0.001
Mean daily
 Fluid balance (mL) 74.2 (− 487.9, 637.26) − 171.56 (− 910.7, 508.88) 369.76 (− 343.8, 1,124.77)  < 0.001
 NEE Score (ug/kg/min) 0.03 (0.01, 0.08) 0.05 (0.02, 0.12) 0.08 (0.03, 0.21)  < 0.001
 Furosemide Dose (mg) 40 (20, 60) 40 (26.67, 75) 53.33 (33.33, 93.12)  < 0.001

SA-AKI sepsis-associated acute kidney injury; RRT renal replacement therapy; NEE norepinephrine equivalent

aMedian (IQR) or frequency (%)

bPearson's Chi-squared test; Kruskal–Wallis rank sum test